Biocon Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Biocon Announces U.S. Commercial Launch of Bosaya and Aukelso , Denosumab Biosimilars".
Biocon Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Biocon Announces U.S. Commercial Launch of Bosaya and Aukelso , Denosumab Biosimilars".